StratGraph
Companies / Financials
ICE

Intercontinental Exchange

Financial Exchanges & Data

Financial Exchanges & DataAnalysis in progress
In progress

We are decoding this company's strategy and relationships

New analyses are published every weekday. Founding members get them first.

Business at a glance

Operating-health scores describe reported fundamentals on a 0–100 scale. They are not a rating of the stock. How they work

Operating health76
Growth53
Profitability100
Cash generationn/a
Balance sheetn/a
Dilution control76
Key ratios and five-year financials
Latest quarter revenue YoY (2026-09-30)20.7%Revenue growth (FY)7.5%Revenue CAGR (3y)9.5%Gross margin—Operating margin39.0%Net margin26.2%Free cash flow margin33.9%R&D / revenue—Stock comp / revenue1.9%Net debt / operating cash flow4.26xCurrent ratio1.02Diluted share count change-0.2%
Fiscal year endingFY 2021-12FY 2022-12FY 2023-12FY 2024-12FY 2025-12
Revenue$9.2B$9.6B$9.9B$11.8B$12.6B
Operating income$3.4B$3.6B$3.7B$4.3B$4.9B
Net income$4.1B$1.4B$2.4B$2.8B$3.3B
Operating cash flow$3.1B$3.6B$3.5B$4.6B$4.7B
Capital expenditure$179M$225M$190M$406M$373M
Free cash flow$2.9B$3.3B$3.4B$4.2B$4.3B
Stock-based comp$188M$155M$257M$231M$238M
Buybacks$250M$632M$0$0$1.3B
Dividends$747M$853M$955M$1.0B$1.1B
Cash$148.0B$1.8B$899M$844M$837M
Total debt$17.0B$18.1B$24.6B$23.4B$20.7B
Equity$22.7B$22.7B$25.7B$27.6B$28.9B

StratGraph publishes general, impersonal research about public companies based on public filings. It is not investment advice, not a recommendation to buy, sell or hold any security, and not tailored to any reader's circumstances. Content may contain errors and may be partly generated with AI tools; verify against the original filings, which are linked. Authors may not trade securities discussed within the window set by our trading policy. Full disclaimer.